MUMBAI/SEOUL -- Two Asian pharmaceutical companies are poised to become key players in the global fight against the new coronavirus pandemic after they were tapped to help mass-produce a promising new vaccine for the disease, which has already killed 650,000 worldwide and infected over 16 million.
Pharmaceuticals
Two Asian pharmas hold key for global supply of Oxford vaccine
India's Serum aims for 400m doses in 2020; S Korea's SK Bioscience keen on exports
Oxford University and AstraZeneca are tying up with Asian companies for mass production of the Oxford vaccine, which this photo shows being injected into a trial participant's arm. (Photo courtesy of Oxford University via AP)
Read Next
Latest on Pharmaceuticals
